A strategic overview for entering and scaling operations across the Atlantic.

For UK-based Life Sciences and Pharma companies, the US remains a key market for international growth, but navigating expansion across the Atlantic brings significant financial, regulatory, and operational complexity.

In this episode, experts from MHA and the BTI network unpack the core challenges that UK companies face when entering or scaling in the US market, including cross-border tax structuring, regulatory compliance, supply chain planning, and talent strategy.

With practical insight and deep international expertise, this discussion highlights how MHA and the BTI network empower UK firms to expand with clarity, confidence, and full compliance — positioning them for long-term success in the world’s largest healthcare market.

Return to listing